Roche: Recognising BioCryst's Potential?
By Business Review Editor
Pharma Deals Review: Vol 2006 Issue 67 (Table of Contents)
Published: 1 Jan-2006
DOI: 10.3833/pdr.v2006.i67.572 ISSN: 1756-7874
Section: Features
Fulltext:
Abstract
After the bad experience of an unfruitful deal with Johnson & Johnson, the US biotech BioCryst Pharmaceuticals has entered into an exclusive licensing agreement with Swiss pharma F...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS